Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Treace Medical Concepts, Inc. TMCI
$25.21
-$0.63 (-2.51%)
На 18:04, 12 мая 2023
+9.08%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
1536241232.00000000
-
week52high
27.97
-
week52low
12.48
-
Revenue
141838000
-
P/E TTM
-31
-
Beta
-0.00609100
-
EPS
-0.80000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 10 авг 2022 г. |
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| BTIG | Buy | 12 мая 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 09 мая 2022 г. |
| Stifel | Buy | Buy | 21 сент 2022 г. |
| BTIG | Buy | Buy | 21 сент 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| MOTT RICHARD W | D | 1155000 | 4011 | 02 февр 2023 г. |
| TREACE JAMES T | D | 1011441 | 11929 | 31 янв 2023 г. |
| TREACE JAMES T | D | 1023370 | 1054 | 30 янв 2023 г. |
| TREACE JAMES T | D | 1024424 | 8803 | 30 янв 2023 г. |
| TREACE JAMES T | D | 1033227 | 28214 | 30 янв 2023 г. |
| MOTT RICHARD W | D | 1159011 | 2039 | 30 янв 2023 г. |
| MOTT RICHARD W | D | 1161050 | 27422 | 30 янв 2023 г. |
| MOTT RICHARD W | D | 1188472 | 61528 | 30 янв 2023 г. |
| BAYS F BARRY | D | 1337614 | 7255 | 25 янв 2023 г. |
| BAYS F BARRY | D | 1344869 | 20467 | 25 янв 2023 г. |
Новостная лента
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
GlobeNewsWire
20 дек 2022 г. в 16:15
PONTE VEDRA, Fla., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ Procedure, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will present the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:30 a.m. Eastern Time.
Recent Price Trend in Treace Medical Concepts (TMCI) is Your Friend, Here's Why
Zacks Investment Research
19 дек 2022 г. в 10:32
Treace Medical Concepts (TMCI) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Treace Medical: Differentiated Offering In Lapiplasty Procedure, Rate Buy
Seeking Alpha
05 дек 2022 г. в 17:52
Treace Medical Concepts, Inc. has a key differentiator in its Lapiplasty procedure, with the potential to create a remedial breakthrough. The company showed strong top-line growth in Q3, reaffirming guidance at 43–44% growth at the top line in FY22.
Treace Medical Concepts (TMCI) is on the Move, Here's Why the Trend Could be Sustainable
Zacks Investment Research
01 дек 2022 г. в 10:32
Treace Medical Concepts (TMCI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Treace Medical Concepts, Inc. (TMCI) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 14:16
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations, Gilmartin Group John Treace - Chief Executive Officer Mark Hair - Chief Financial Officer Conference Call Participants Lilia-Celine Breton Lozada - JPMorgan Andrew Ranieri - Morgan Stanley Ryan Zimmerman - BTIG Rick Wise - Stifel Vivian Cervantes Good afternoon, everyone, and welcome to our Third Quarter 2022 Earnings Conference Call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer.